Aptevo Therapeutics Inc. — Director's Dealing 2022

Aug 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2022-08-09

Reporting Person: Grant Grady III (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-09	Restricted Stock Unit	$	A	3571	Acquired		Common Stock (3571)	Direct

Footnotes

F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2: The RSUs vest in full on the first anniversary of the date of grant.